Funded Startups in Morristown
Among the 11 most recent funded entries shown, the largest disclosed round is $68M for G.S.
Among the 11 most recent funded entries shown, the largest disclosed round is $68M for G.S. Wilcox & Co. on 2025-04-21. That $68M figure dwarfs the next-largest disclosed amount of $25M (Cingulate Therapeutics, 2025-07-21) and sits well above other disclosed rounds clustered mostly below the $22M mark (e.g., BioAegis Therapeutics at $22M on 2022-03-22; The Ryl Company at $15M on 2025-04-14). The list also shows a dense temporal cluster in 2025: five of the 11 rounds fall between 2025-02-18 and 2025-07-21, with multiple companies headquartered in Morristown, New Jersey.
Geographically, 9 of 11 entries are explicitly in Morristown, New Jersey (the other two are Eskola in Morristown, Tennessee; and all remaining entries remain in NJ). Sector-wise, Biotechnology appears 3 times (Cingulate Therapeutics, BioAegis Therapeutics, Neumentum), while “Series Unknown” appears 5 times and “undisclosed” appears once (Eskola, 2025-02-11). Dates span from 2021-10-20 (Neumentum) through 2025-07-21 (Cingulate Therapeutics).
Most recent rounds
11 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Morristown list, and how much higher is it than the rest?
G.S. Wilcox & Co. raised the largest disclosed amount at $68M on 2025-04-21. The next-largest disclosed figure is $25M for Cingulate Therapeutics on 2025-07-21, with most other disclosed rounds including $22M (BioAegis Therapeutics, 2022-03-22) and $15M (The Ryl Company, 2025-04-14) staying well below $25M.
Do the most recent rounds cluster within a short time window?
Yes. Five of the 11 rows are dated in 2025, spanning from 2025-02-18 (DiligentIQ, $12M) through 2025-07-21 (Cingulate Therapeutics, $25M). The 2025 portion also includes two April closings in Morristown, New Jersey—G.S. Wilcox & Co. ($68M) on 2025-04-21 and The Ryl Company ($15M) on 2025-04-14.
Is Morristown, New Jersey the dominant geography among these entries?
It is. Nine of 11 entries list Morristown, New Jersey (e.g., DiligentIQ on 2025-02-18 for $12M; TripWorks on 2023-11-09 as undisclosed). The two exceptions are Eskola in Morristown, Tennessee (2025-02-11, undisclosed) and none other listed outside NJ.
How does the stage/round classification split—are “Series Unknown” and “undisclosed” common?
“Series Unknown” appears in 5 of 11 rows (including Cingulate Therapeutics on 2025-07-21 and G.S. Wilcox & Co. on 2025-04-21). “undisclosed” appears once (Eskola on 2025-02-11), while the remaining labeled stages include Seed (vipHomeLink, $2M on 2023-10-26; TripWorks is undisclosed on 2023-11-09) plus Series A (DiligentIQ, $12M on 2025-02-18) and Series B (The Ryl Company, $15M on 2025-04-14).
Are there sector clusters or outlier sectors within this set?
Biotechnology is a visible cluster with 3 entries: Cingulate Therapeutics ($25M, 2025-07-21), BioAegis Therapeutics ($22M, 2022-03-22), and Neumentum ($13M, 2021-10-20). An outlier by amount is G.S. Wilcox & Co. in Financial Services ($68M on 2025-04-21), which is far larger than other disclosed rounds in the list (e.g., OmniActive Health Technologies at $100K on 2022-03-01).
Which entries sit at the temporal edges of the dataset shown?
The most recent row is Cingulate Therapeutics on 2025-07-21 with a disclosed $25M. The oldest row shown is Neumentum on 2021-10-20 with a disclosed $13M, placing the observed span at roughly 3 years between those two dates.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.